SURMODICS INC — Director's Dealing 2021

May 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-05-20

Reporting Person: Stich Joseph J. (SVP, HR and GM, IVD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-20	Common Stock	S	2500	$53.8022	Disposed	45776	Direct
2021-05-20	Common Stock	G	1000	$0.00	Disposed	44776	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021

F2: Reflects the weighted average price of 2,500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on May 20, 2021 with sale prices ranging from $53.42 to $54.265 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes 214 shares acquired through the Employee Stock Purchase Plan for the phase ending February 26, 2021.